qPCR Fluorescence Mutation Detection for Accurate Variant Classification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional systems for detecting virus variants, such as SARS-CoV-2, in nucleic acid samples using quantitative Polymerase Chain Reaction (qPCR) operations are prone to high levels of false positives due to inadequate noise baselines, leading to inaccurate high-confidence detection.
Innovation Solution
A system utilizing a thermal cycler and analytics system that performs a multiple mutation assay with control and mutation probes, analyzing fluorescence signals through quantitative cycle (Cq) and relative fluorescence unit (RFU) thresholds to identify specific mutations, enabling high-confidence variant classification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If traditional qPCR systems use a simple noise baseline for fluorescence signal detection, then the system is easy to operate, but it produces high levels of false positives in variant detection
Solution Approach 1:
The patent segments the fluorescence signal analysis into multiple components: baseline fluorescence, slope of the amplification curve, and threshold crossing points. By dividing the detection into these segments, the system can evaluate each component separately to determine true positives, reducing false positives while maintaining operational simplicity through automated multi-parameter evaluation.
Solution Approach 2:
The patent changes the detection parameters from a single baseline threshold to multiple parameters including baseline fluorescence level, amplification slope, and cycle threshold (Cq) values. This parameter transformation allows the system to distinguish between true variants and false positives by evaluating the pattern across multiple parameters rather than relying on a single inadequate baseline comparison.
2Device complexity
If traditional systems use a single baseline threshold for fluorescence detection, then the measurement process is simple, but the measurement precision is insufficient for high-confidence variant detection
Solution Approach 1:
The patent adds multiple dimensions to the detection analysis by evaluating fluorescence signals across different parameters: baseline level, slope magnitude, Cq value, and amplification curve shape. This dimensional expansion transforms a single-threshold one-dimensional detection into a multi-parameter multi-dimensional evaluation, significantly improving precision while keeping the automated process relatively simple.
Solution Approach 2:
The patent introduces intermediary calculation steps including baseline subtraction, slope calculation, and Cq threshold determination as intermediate layers between the raw fluorescence signal and the final detection decision. These intermediary computations refine the signal characterization and enable high-confidence variant identification by mediating the complex relationship between raw data and detection outcome.
3Measurement precision
If the system implements comprehensive multiple mutation assays with multiple probes, then the detection precision and variant classification accuracy improve, but the device complexity and assay complexity increase
Solution Approach 1:
The patent merges multiple mutation detection probes into a single integrated qPCR assay that analyzes multiple genomic regions simultaneously. By combining multiple probe targets into one unified reaction system with shared reagents and thermal cycling, the system achieves high-precision multi-variant detection without proportionally increasing operational complexity, as all probes are evaluated through the same automated analysis pipeline.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system provides accurate and reliable detection of virus variants by distinguishing between true and false positives, allowing for precise variant identification and reporting, along with treatment recommendations and variant metrics.
Implementation Method 1
the thermal cycler can cycle through a denaturation phase, an annealing phase, and an extension phase to amplify target genomic regions
Implementation Method 2
The thermal cycler includes one or more light sources for exciting the fluorophores on the extended amplificons
Implementation Method 3
one or more light detectors for measuring fluorescence signal from a sample
Data Source
AI summary
A system and method for SARS-CoV-2 variant classification through mutation detection from qPCR fluorescence signals. The system receives fluorescence signals, wherein a first fluorescence signal indicates quantitative presence of a first genomic region as a control for SARS-CoV-2, and a second fluorescence signal indicates quantitative presence of a second genomic region of a first mutation present in a subset of variants of SARS-CoV-2. The system measures a first Cq for the first fluorescence signal and a second Cq for the second fluorescence signal as the signals cross a threshold RFU. The system calculates a delta Cq as a difference between the two. Further, the system identifies a first peak RFU for the first fluorescence signal and a second peak RFU for the second fluorescence signal, and calculates a RFU ratio of the two. The system detects presence of the first mutation based on the delta Cq and/or the RFU ratio.